The Series A round of funding announced Tuesday was led by Amplitude Ventures and Fonds de solidarité FTQ. Montreal-based Congruence uses mathematical modeling, physics, and machine learning to ...
Congruence pulls in $50M series A to build a team of 'drug hunters' to go after rare disease targets
A new biotech called Congruence Therapeutics snagged $50 million to build a new team of "drug hunters" focused on protein misfolding to go after rare diseases. Congruence Therapeutics just completed a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results